Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 132

    1.

    Effects of pesticides on the ratio of 16 alpha/2-hydroxyestrone: a biologic marker of breast cancer risk.

    Bradlow HL, Davis DL, Lin G, Sepkovic D, Tiwari R.

    Environ Health Perspect. 1995 Oct;103 Suppl 7:147-50.PMID: 8593862 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk.

    Ho GH, Luo XW, Ji CY, Foo SC, Ng EH.

    Ann Acad Med Singapore. 1998 Mar;27(2):294-9.PMID: 9663330 [PubMed - indexed for MEDLINE]Related articles

    4.

    Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk.

    Taioli E, Bradlow HL, Garbers SV, Sepkovic DW, Osborne MP, Trachman J, Ganguly S, Garte SJ.

    Cancer Detect Prev. 1999;23(3):232-7.PMID: 10337002 [PubMed - indexed for MEDLINE]Related articles

    5.

    Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.

    Ursin G, London S, Yang D, Tseng CC, Pike MC, Bernstein L, Stanczyk FZ, Gentzschein E.

    Breast Cancer Res Treat. 2002 Mar;72(2):139-43.PMID: 12038704 [PubMed - indexed for MEDLINE]Related articles

    7.

    Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.

    Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, Sutter T.

    Biochim Biophys Acta. 2006 Aug;1766(1):63-78. Epub 2006 Apr 19. Review.PMID: 16675129 [PubMed - indexed for MEDLINE]Related articles

    8.

    2-hydroxyestrone: the 'good' estrogen.

    Bradlow HL, Telang NT, Sepkovic DW, Osborne MP.

    J Endocrinol. 1996 Sep;150 Suppl:S259-65. Review.PMID: 8943806 [PubMed - indexed for MEDLINE]Related articles

    9.

    Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells.

    Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL.

    J Natl Cancer Inst. 1992 Apr 15;84(8):634-8.PMID: 1556774 [PubMed - indexed for MEDLINE]Related articles

    10.

    Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.

    Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC.

    J Natl Cancer Inst. 1999 Jun 16;91(12):1067-72.PMID: 10379970 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells.

    Suto A, Bradlow HL, Wong GY, Osborne MP, Telang NT.

    Breast Cancer Res Treat. 1993 Sep;27(3):193-202.PMID: 8312577 [PubMed - indexed for MEDLINE]Related articles

    13.

    Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells.

    Gupta M, McDougal A, Safe S.

    J Steroid Biochem Mol Biol. 1998 Dec;67(5-6):413-9.PMID: 10030690 [PubMed - indexed for MEDLINE]Related articles

    14.

    The relationship between physical activity and 2-hydroxyestrone, 16alpha-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States).

    Bentz AT, Schneider CM, Westerlind KC.

    Cancer Causes Control. 2005 May;16(4):455-61.PMID: 15953988 [PubMed - indexed for MEDLINE]Related articles

    15.

    Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women.

    Riza E, dos Santos Silva I, De Stavola B, Bradlow HL, Sepkovic DW, Linos D, Linos A.

    Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):627-34.PMID: 11401912 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.

    Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC.

    Environ Health Perspect. 1997 Apr;105 Suppl 3:601-5.PMID: 9168002 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    In Vitro and In Vivo Modulation of Growth Regulation in the Human Breast Cancer Cell Line MCF-7 by Estradiol Metabolites.

    Suto A, Telang NT, Tanino H, Takeshita T, Ohmiya H, Osborne MP, Kubota T.

    Breast Cancer. 1999 Apr 2;6(2):87-92.PMID: 11091698 [PubMed - as supplied by publisher]Related articles

    18.

    A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid.

    Falk RT, Rossi SC, Fears TR, Sepkovic DW, Migella A, Adlercreutz H, Donaldson J, Bradlow HL, Ziegler RG.

    Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):81-7.PMID: 10667467 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Estrogen metabolites and the risk of breast cancer in older women.

    Cauley JA, Zmuda JM, Danielson ME, Ljung BM, Bauer DC, Cummings SR, Kuller LH.

    Epidemiology. 2003 Nov;14(6):740-4.PMID: 14569192 [PubMed - indexed for MEDLINE]Related articles

    20.

    Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.

    Seeger H, Wallwiener D, Kraemer E, Mueck AO.

    Maturitas. 2006 Apr 20;54(1):72-7. Epub 2005 Oct 4.PMID: 16213115 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data